Investor Relations
Investor access
This page is for prospective investors in US Defense Technology Solutions LLC. Enter the investor password to view the seed round materials.
Need access? Contact us.
Confidential · Seed Round 2026
Every competitor stops the bullet. We manage what happens next.
Defy Impact is the first trauma shock prevention system for personnel protection. Our Level 5 Mass-Adaptive Chassis decouples the armor plate from the wearer, cutting felt kinetic energy by up to 70% and addressing behind-armor blunt trauma, a threat today's armor standards don't measure.
Why Defy Impact
Investment highlights
A category of one
The only product addressing behind-armor blunt trauma at a systems-engineering level. Crye, Safariland and Point Blank all stop the round; none manage the energy that follows.
Patent-pending architecture
21 claims across four claim families, covering the decoupled chassis, dual-rate energy dissipation, integrated active O₂ and impact sensing.
90% gross margin
$3,500 MSRP against roughly $350 cost of goods, built on standard industrial components that scale.
200:1 taxpayer ROI
One prevented traumatic brain injury (about $500K in lifetime care) funds 142 Guardian units. The buyer's budget case writes itself.
Intellectual Property
Protected at the architecture level.
The claims cover how the whole system works together, not a single material or part, so a competitor can't design around it by swapping a component.
- Title
- Wearable Ballistic Protection Apparatus
- Application
- U.S. Patent Application No. 64/033,279
- Filed
- April 8, 2026
- Owner
- US Defense Technology Solutions LLC (assignment recorded with the USPTO)
- Inventor
- Joachim Peralta
- Counsel
- Bamert Regan PLLC, Seattle, WA
- Compliance
- Berry Amendment and ITAR compliant, 100% U.S. manufactured
Independent patentability search, January 2026: a formal search of USPTO, EPO and WIPO databases found no single prior-art reference disclosing the claimed combination of quad-point linear guidance, dual-rate damping and integrated life support.
The full search report is available under NDA.
Core apparatus
The decoupled chassis with a floating plate on quad-point linear suspension, 20–30mm of controlled travel and automatic mechanical reset after every hit.
Energy dissipation
Dual-rate variable resistance dampers, the zero-stop safety limit that keeps the plate off the sternum, and sub-2ms recoil initiation.
Active O₂ system
Turns the suspension's air gap into housing for oxygen enrichment and heat purging, with gas mask and PAPR integration.
Sensing and method
Real-time impact severity sensing for automatic triage, pelvic load transfer, and an independent method claim protecting the injury-attenuation process itself.
Market
$682M domestic addressable market.
195,000 units across two verticals, served by one platform at a $3,500 MSRP.
The Vanguard
$402.5M TAM · 115,000 units. SOCOM optimized, entering through T&E seeding toward a DoD Program of Record.
The Guardian
$280M TAM · 80,000 units. 5.5 lb chassis for domestic law enforcement, purchasable with DHS / BVP grant funding.
Projections
Revenue, years 1–3.
From pilot seeding to Program of Record.
Use of Funds
Where the $2.5M goes.
Three divisions, each staffed for a specific barrier between the prototype and a procurement contract.
Prototype refinement and ballistic testing
NIJ / DoD standards work and pilot program operations
Manufacturing, ITAR and Berry Amendment setup
Go-to-Market
Three phases to market leadership.
Pilot seeding
50–100 Guardian units deployed at cost to Tier 1 law enforcement and SOCOM units for real-world test and evaluation.
Standards
Work with NIJ and DoD standards bodies to add trauma-mitigation metrics to procurement specifications.
Grant alignment
Grant-ready kits packaged for DHS / BVP funding cycles, so agencies can buy with federal dollars.
Documents
Investor materials
Next Steps
From first look to diligence.
Review the deck
The 14-page investor presentation covers the problem, the technology, market and projections.
Sign and return the NDA
Download the NDA, sign it on behalf of yourself or your firm, and email it to contact@defyimpact.com.
Diligence
Once the NDA is in place we'll share the patent application and figures, the patentability search report, the investment memorandum and the pro forma.
Meet the team
Schedule a call with our founder, Joachim Peralta.
This page is provided for informational purposes to prospective investors and does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. Any offering will be made only through definitive offering documents. Projections, market figures and performance figures are forward-looking estimates by the company, are not guarantees of future results, and involve risks and uncertainties. All information on this page is confidential.